financetom
Business
financetom
/
Business
/
Why Is Crocs Stock Falling Thursday?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Why Is Crocs Stock Falling Thursday?
Apr 30, 2026 8:29 AM

Crocs, Inc. ( CROX ) shares traded lower Thursday after the footwear maker reported a mixed first-quarter performance, as strength in its core brand and raised guidance failed to offset weakness in HEYDUDE and margin compression.

Earnings Beat Expectations, But Revenue Declines

The company posted adjusted earnings of $2.99 per share, topping the analyst consensus estimate of $2.77. Revenue declined 1.7% year over year to $921.5 million, but still exceeded expectations of $900.9 million.

Crocs brand revenue rose 0.8% to $767 million, though it declined 1.9% on a constant-currency basis. HEYDUDE revenue fell 12.3% to $154 million, or 13.2% on a constant-currency basis.

Direct-to-consumer sales increased 12.1%, or 10.2% on a constant-currency basis, while wholesale revenue dropped 9.9%, or 12.5% on a constant-currency basis.

Margins Under Pressure Despite Revenue Beat

Profitability weakened during the quarter. Adjusted gross margin declined 90 basis points to 56.9%. Adjusted operating income fell 7.8% to $206 million, resulting in an adjusted operating margin of 22.3%, down from 23.8% a year earlier.

Crocs ( CROX ) ended the quarter with $131 million in cash and equivalents.

Annual Outlook Raised

Looking ahead, the company raised its full-year 2026 adjusted earnings guidance to a range of $13.20 to $13.75 per share, up from its prior outlook of $12.88 to $13.35. The updated range compares with the current consensus estimate of $13.34.

For 2026, Crocs ( CROX ) expects its core brand revenue to be flat to up 2%, while HEYDUDE revenue is projected to decline 5% to 7%, an improvement from earlier guidance.

For the second quarter, Crocs ( CROX ) forecasts adjusted earnings of $4.15 to $4.35 per share, compared with the consensus estimate of $4.30. The company expects revenue to come in below $1.149 billion, versus estimates of $1.127 billion.

Crocs ( CROX ) projects second-quarter core brand revenue growth of 1% to 3%, while HEYDUDE revenue is expected to fall 12% to 14%. Adjusted operating margin is anticipated to be about 24.7%.

CROX Price Action: Crocs ( CROX ) shares were down 1.29% at $98.85 at the time of publication on Thursday, according to Benzinga Pro data.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Why Is Crocs Stock Falling Thursday?
Why Is Crocs Stock Falling Thursday?
Apr 30, 2026
Crocs, Inc. ( CROX ) shares traded lower Thursday after the footwear maker reported a mixed first-quarter performance, as strength in its core brand and raised guidance failed to offset weakness in HEYDUDE and margin compression. Earnings Beat Expectations, But Revenue Declines The company posted adjusted earnings of $2.99 per share, topping the analyst consensus estimate of $2.77. Revenue declined...
--B. Riley Adjusts Universal Technical Institute PT to $49 From $36, Maintains Buy Rating
--B. Riley Adjusts Universal Technical Institute PT to $49 From $36, Maintains Buy Rating
Apr 30, 2026
11:10 AM EDT, 04/30/2026 (MT Newswires) -- Price: 37.75, Change: +1.67, Percent Change: +4.63 ...
Ideaya Biosciences Moves Darovasertib Toward FDA Review After Positive Trial Readout
Ideaya Biosciences Moves Darovasertib Toward FDA Review After Positive Trial Readout
Apr 30, 2026
11:08 AM EDT, 04/30/2026 (MT Newswires) -- Ideaya Biosciences ( IDYA ) said the US Food and Drug Administration agreed to review its new drug application for darovasertib in combination with crizotinib for patients with first-line HLA*A2-negative metastatic uveal melanoma under the agency's Oncology Center of Excellence Real-Time Oncology Review program. The phase 2/3 trial of darovasertib in combination with...
US telecom agency votes to expand tech crackdown on China
US telecom agency votes to expand tech crackdown on China
Apr 30, 2026
WASHINGTON, April 30 (Reuters) - The Federal Communications Commission on Thursday voted to advance a proposal to bar all Chinese labs from testing electronic devices such as smartphones, cameras and computers for use in the United States. The FCC is also set take an initial vote on Thursday on a separate proposal to bar three major Chinese telecom companies from...
Copyright 2023-2026 - www.financetom.com All Rights Reserved